Oytun, M. G. Et Al. 2023. Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital. International Journal of Diabetes in Developing Countries , vol.43, no.5 , 758-764.

Oytun, M. G., CEYLAN, S., Koca, M., Öztürk, Y., Baş, A. O., BALCI, C., ... DOĞU, B. B.(2023). Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital. International Journal of Diabetes in Developing Countries , vol.43, no.5, 758-764.

Oytun, Merve Et Al. "Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital," International Journal of Diabetes in Developing Countries , vol.43, no.5, 758-764, 2023

Oytun, Merve G. Et Al. "Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital." International Journal of Diabetes in Developing Countries , vol.43, no.5, pp.758-764, 2023

Oytun, M. G. Et Al. (2023) . "Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital." International Journal of Diabetes in Developing Countries , vol.43, no.5, pp.758-764.

@article{article, author={Merve Güner Oytun Et Al. }, title={Benefits vs risks: SGLT-2 inhibitors in older adults living with frailty: a retrospective study from a university hospital}, journal={International Journal of Diabetes in Developing Countries}, year=2023, pages={758-764} }